11-823586-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020376.4(PNPLA2):āc.756C>Gā(p.Asn252Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,529,560 control chromosomes in the GnomAD database, including 143 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_020376.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PNPLA2 | NM_020376.4 | c.756C>G | p.Asn252Lys | missense_variant, splice_region_variant | 6/10 | ENST00000336615.9 | NP_065109.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PNPLA2 | ENST00000336615.9 | c.756C>G | p.Asn252Lys | missense_variant, splice_region_variant | 6/10 | 1 | NM_020376.4 | ENSP00000337701.4 |
Frequencies
GnomAD3 genomes AF: 0.00907 AC: 1346AN: 148426Hom.: 10 Cov.: 32
GnomAD3 exomes AF: 0.00895 AC: 2160AN: 241390Hom.: 14 AF XY: 0.00913 AC XY: 1200AN XY: 131376
GnomAD4 exome AF: 0.0125 AC: 17293AN: 1380972Hom.: 133 Cov.: 37 AF XY: 0.0123 AC XY: 8459AN XY: 689034
GnomAD4 genome AF: 0.00905 AC: 1345AN: 148588Hom.: 10 Cov.: 32 AF XY: 0.00877 AC XY: 637AN XY: 72642
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 19, 2021 | This variant is associated with the following publications: (PMID: 21170305, 30389748) - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | PNPLA2: BS1, BS2 - |
Neutral lipid storage myopathy Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at